Table 1.
Increases in the prevalence of some common human diseases and disorders, and releationship to genotype, epigenetic factors and environmental agents.
| Disorder | GWAS | % variance explained or OR | Increase in prevalence | Epigenetic effect | Environmental agents |
|---|---|---|---|---|---|
| Obesity | Y | <10% [311] | 100% between 1991 and 2011 |
Y | EDCs, obesogens, arsenic, maternal obesity and maternal diabetes |
| Diabetes | Y | Average OR: 1.18 for ten SNPs with strong association [312] |
176% between 1980 and 2010 |
Y | EDCs |
| Asthma | Y | OR: 1.08–2.04 for SNPs associated with non-toluene- induced disease [313] |
75% between 1980 and 1994 |
Y | Second-hand smoke, automobile exhausts and industrial emissions |
| ADHD | Y | OR: 0.45–1.65 for top 25 SNPs [314] |
33% between 1997 and 2008 |
Y | EDCs |
| ASD | Y | OR: 0.56–1.19 for five SNPs with strongest association [315] |
289.5% between 1997 and 2008 |
Y | EDCs |
| Hypertension | Y | OR: 0.85–0.9, few SNPs confirmed except in extreme case–control designs [316] |
60% between 1995 and 2005 |
Y | EDCs and maternal diet |
| Low birthweight |
N | Not available | Increased use of assisted reproduction, advanced maternal age |
Y | PFOS, PFOA and covariates |
| Cancer | Y | OR: 1.1–2.5, depending on disease [317] |
Overall cancer rates are in decline since 2008, but specific cancers (e.g., lung cancer in women) are increasing and some are linked to environmental factors |
Y | BPA, cadmium, arsenic and dioxins |
ADHD: Attention deficit hyperactivity disorder; ASD: Autism spectrum disorder; BPA: Bisphenol A; EDC: Endocrine-disrupting compound; GWAS: Genome-wide association study; N: No; OR: Odds ratio; PFOA: Perfluorooctanesulfonic acid; PFOS: Perfluorooctanoic acid; Y: Yes.